After the unblocking of Shanghai, the seventh batch of collection was officially launched.

After the unblocking of Shanghai, the seventh batch of collection of collection finally came.

On June 20, Shanghai Sunshine Procurement Network issued the "National Pharmaceutical Pharmaceutical Purchase Documents" stated that it officially opened the seventh batch of pharmaceutical collection and mining work. According to the regulations, all enterprises need to complete the material application work on July 12, and the bid opening location is still Shanghai Fengxian Oriental Meiyu Forum Hotel.

The seventh batch of 61 varieties, including Aafrtini, and 61 varieties, including Afutoni, and anchidazole oral collapse. There are as many as 300 companies involved in these varieties, of which there are heavy products for some well -known enterprises.

Omeprazole injection, which was originally researched by Astraon, is one of the most watched products this time. According to Mine.com, the sales of this drug in public medical institutions in the country in 2021 exceeded 4 billion yuan. Astraikon had lagged behind Olympic Kang and the market share ranked second.

But it is undeniable that the Omeprazole series is still an important golden stone in the Chinese market in the Chinese market. In 2019, the total sales of Ameprazole public hospitals in injection exceeded 5 billion yuan for the first time, and Astraon accounted for 63.22%. Among the fifth batch of national collection, Astrakang's original research was not bidd in injection.

This time, will Astraik do not reduce the price as the previous few times? It can be seen in July.

The nifedo -benzen -horizontal control type is also included in the collection list. This is a commonly used antihypertensive drug. The original research manufacturer enlightened about 70 % of the domestic market. At present, including Bayer, 10 domestic companies are satisfied with the qualifications for collecting collection.

Since 2021, the varieties of Guotai have repeatedly disrupted the safety of medication. To this end, the seventh batch of collective land has increased the option of "alternative enterprises".

The "Procurement Documents" stipulates that in addition to the selection of "main supply areas", it is necessary to select the "preparation area" from the main regions of other companies in the order of the middle school. The selected enterprise is directly hung in the preparation area according to the mid -range price. Once the main supply enterprise cannot be supplied, the company can win the "main supply" identity.

In August 2021, the ibuprofen -release capsules of North China Pharmaceuticals were interrupted in Shandong. The State Medical Insurance Bureau included North China Pharmaceutical on the "illegal list" and canceled its qualifications to participate in the national collection. It was not restored until May this year. The out -of -stock storm caused by this incident once made the National Medical Insurance Agency very embarrassed, so the "preparation" option was added in the seventh batch of collecting rules.

Setting "dual insurance", although the terminal medication is guaranteed, it also brings greater variables to the enterprise. Originally, the enterprise estimated its own quotation in accordance with the proposed purchase volume, but now it is necessary to consider the factors of the preparation. When calculating the price, a large amount of supply must be considered. Enterprises must not only ensure their own production capacity to meet the needs of confession, but also consider costs, pricing, etc.

It is expected that in this national collection, corporate bargaining will become cautious because of the "preparation option".

However, the competition relationship determines that the price reduction of the seventh batch of national collection will not be too low. According to the statistics of the industry media "Fengyun Pharmaceutical Talk", among the seventh batch of production companies with more than 10 products, this number is far more than before; There are 33%.

Data show that among the first six batches of seven -wheeled national collection, a total of 268 specimen of procurement varieties involved, of which 234 products were selected, with an average decrease of 53%and a maximum decrease of 99%. The seventh batch of price reductions should be maintained at this range.

- END -